New heart failure drug could reduce death by 20 per cent, trial shows

A new drug for heart failure could reduce the number of deaths from the disease by 20%, and is the first treatment in two decades to show a higher survival rate for patients, says one of BC’s top cardiologists.

Dr. Andrew Ignaszewski, head of cardiology at St. Paul’s Hospital, is one of the lead researchers into the largest heart failure study to date and was in Spain on Saturday to present the findings at the European Society of Cardiology.

He called the findings a major advancement in heart failure treatment.

Tiffany Crawford reports

Stroke of Luck

Jacques Lalonde is trying to reach his thumb to his pinky. Just more than a year after suffering a stroke, that’s one of the daily exercises the 51-year-old performer is doing to regain mobility in his right hand. Lalonde’s record for touching his two digits without fumbling or stopping due to exhaustion or frustration is five times in a row.

Experimental heart surgery survivor to throw ceremonial pitch

A Comox woman who was one of the first people to have her broken heart fixed with an experimental surgery has been asked to throw the first pitch at an upcoming Vancouver Canadians baseball game. Sharon Daly, 67, is nervous about winding up at the Nat Bailey Stadium August 14, but she has already overcome a much bigger challenge—surviving a new kind of bovine valve operation six years ago.

“Oh my gosh! Not me,” she said, describing how it felt to be told her heart problem meant she might have just three to five years to live.

St. Paul's takes on interns

Monday, August 11, 2014: A new medical program is giving inner city kids from Dallas the chance to learn from heart and lung researchers at St Paul’s Hospital.

Elaine Yong reports

Click here to view the video

Mechanical CPR saves lives

VANCOUVER—If there’s a good time and place to go into cardiac arrest, William Terzianoff, 59, found it. The grandfather collapsed in the parking lot in front of his Kitsilano apartment, seconds away from a massive heart attack. But fortunately, the head of St. Paul’s Hospital’s emergency department was going for dinner in the area and started CPR on Terzianoff. He was rushed to hospital and a new, mechanical chest compression device was used to save his life. It replaces manual CPR and doctors say it saves lives. Terzianoff agrees.

Marlisse Silver Sweeney reports

Survival over 80% after valve-in-valve implantation

For patients with failed surgical bioprosthetic valves, one-year survival after transcatheter valve-in-valve implantation is 83.2%, according to a study published in the July 9 issue of the Journal of the American Medical Association.

Study examines survival following repair of failed bioprosthetic aortic valves

In an analysis of about 460 patients with failed bioprosthetic aortic valves who underwent transcatheter valve-in-valve implantation, overall survival at one year was 83 percent, with survival associated with surgical valve size and mechanism of failure, according to a study in the July 9 issue of the Journal of the American Medical Association.

Click here to read the full story

Paul Terry: driven to succeed

At first blush, Phemi Health Systems sounds a bit like one of those startups from HBO's Silicon Valley that have developed yet another health-care app that promises to make the world a better place.

But take a peek under the hood and it is instantly apparent that this is no ordinary startup, but one with some serious entrepreneurial horsepower and business bona fides behind it.

 Dominic Schaefer reports

St. Paul’s Hospital performs first new non-invasive heart surgery

A new non-invasive heart surgery is being considered a breakthrough for people who previously had no treatment options available.

There is a new procedure available for the one-in-10 people over the age of 75 with the heart condition “mitral regurgitation,” which is a leaking valve in the heart.


Subscribe to RSS - Heart/Lung